Clinical Trials on Bone Marrow Disease in France

Total 34873 results

University Hospital, Lille

Completed

Study of Normal Hip and Lumbar Bone Marrow With Dynamic Contrast Enhancement Magnetic Resonance Imaging (PERFOS)

Bone Marrow

France
Assistance Publique - Hôpitaux de Paris

Recruiting

French National Registry of Bone Marrow Failures (RIME)

Bone Marrow Failure Syndrome

France
Rennes University Hospital

Recruiting

QUALHYBOM Hypnosis Versus Equimolar Mixture of Oxygen and Nitrous Oxide (MEOPA) During a Bone Marrow Biopsy: a Clinical, Controlled, Randomized, Multicenter Study (QUALHYBOM)

Bone Marrow Biopsy

France
European Society for Blood and Marrow Transplantation

Enrolling by invitation

RACE 2: a Long Term Follow-up of Patients Participating in the RACE Trial (RACE2)

Severe Aplastic Anemia

France
University Hospital, Lille

Completed

Bone Marrow Adiposity and Fragility Fractures in Postmenopausal Women (ADIMOS)

Fractures, Bone | Adiposity | Bone Marrow Disease | Fat Disorder

France
Assistance Publique Hopitaux De Marseille

Unknown

Natural Killer Cells and Polycythemia Vera (Vaquez's Disease)

Polycythemia Vera

France
PV-Nord

Completed

Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera

Polycythemia Vera

France
European Society for Blood and Marrow Transplantation
Genzyme, a Sanofi Company

Completed

Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic Anaemia (RATGAA07)

Aplastic Anemia

Switzerland, United Kingdom, Germany, Italy, France, Saudi Arabia
Centre Hospitalier Universitaire de Nice
Centre National de la Recherche Scientifique, France

Terminated

Exploring the Mechanisms of Resistance of Stem Cells Myeloproliferative Opposite of Tyrosine Kinase Inhibitors in 3d Model Niche Endosteal

Myeloproliferative Disorders

France
Centre Henri Becquerel

Unknown

Pain Management With Pecfent in the Prevention of Pain Induced by Position in Radiotherapy (PARABONE)

Bone Metastasis

France
Institut Bergonié
French Sarcoma Group

Active, not recruiting

Patterns of Care and Outcomes in Patients With Metastatic Bone Tumors (METABONE) (METABONE)

Metastatic Bone Tumor

France
Theraclion

Completed

Antalgic Treatment of Painful Bone Metastases by US-guided High Intensity Focused Ultrasound (HIFU)

Bone Metastasis

France
Assistance Publique - Hôpitaux de Paris
National Research Agency, France

Unknown

Toward Immune Biomarkers for Tolerance and GvHD in Humans (BioGvHD)

Bone Marrow Transplantation | Hematopoietic Stem Cell Transplantation | Graft vs Host Disease

France
Fondation Ophtalmologique Adolphe de Rothschild

Completed

Subconjunctival Injection of Allogeneic Mesenchymal Stem Cells in Severe Ocular Chemical Burn (SYMBOLpreclini)

Bone Marrow Donor

France
Hospices Civils de Lyon

Not yet recruiting

Blood Viscosity in Polycythemia Patients (POLYVISCO)

Polycythemia Secondary | Polycythemia, Primary

France
Assistance Publique - Hôpitaux de Paris

Completed

JAK-STAT Signalling Pathway in Familial Myeloproliferative Disorders (SMP)

Myeloproliferative Disorders

France
University Hospital, Brest

Completed

Drug Observance and Side Effects of Cytoreductive Drugs in PV and ET Patients (OUEST)

Polycythemia Vera | Essential Thrombocythemia

France
Centre Hospitalier Universitaire de Nīmes

Active, not recruiting

Functional Characterization of Thrombopoietin/cMPL Receptor Mutations in Myeloproliferative Neoplasia (MPL - NPM)

Myeloproliferative Disorder

France
University Hospital, Brest

Recruiting

Myeloproliferative Neoplastic Diseases Observatory From Brest (OBENE)

Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia

France
Nantes University Hospital

Terminated

Bone Demineralization Lesions in the Injured Marrow: Efficacy and Tolerability of Administration Early and Repeated the Zoledronic Acid. Comparative Study, Prospective, Double-blind Controlled (DBMZol) (DBMZol)

Bone Demineralization Lesions in the Injured Marrow

France
Assistance Publique - Hôpitaux de Paris
EuroFancolen

Completed

Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and Plerixafor (FancoMob)

Fanconi Anemia

France
Institut National de la Santé Et de la Recherche...

Recruiting

Mechanism of Action of Interferon in the Treatment of Myeloproliferative Neoplasms (IFN&SMP)

Myeloproliferative Neoplasm

France
Assistance Publique - Hôpitaux de Paris

Unknown

Clinical and Therapeutic Impact of Molecular Markers in Myeloproliferative Disorders (CTIM3)

Myeloproliferative Neoplasms

France
Assistance Publique - Hôpitaux de Paris

Completed

Cord Blood Transplantation in Severe Aplastic Anemia (APCORD)

Hereditary Diseases | Relapse | Acquired Aplastic Anemia | Absence of an HLA Identical Donor

France
Genzyme, a Sanofi Company

Completed

Registry of Patients Treated With Plerixafor (Mozobil®) for Haematopoietic Stem Cell Mobilization Before Autologous Transplantation

Bone Marrow / Autologous Transplants

France
French Innovative Leukemia Organisation

Completed

Trial Ruxolitinib and Peg-interferon Alpha-2a Combination in Patients With Primary Myelofibrosis RUXOPeg (RUXOPeg)

Myelofibrosis

France
Centre Leon Berard

Recruiting

Feasibility Study to Assess an Adapted Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Transplantation (EVAADE)

Myelodysplastic Syndromes | Severe Combined Immunodeficiency | Acute Leukemia | Haematological Malignancy | Hemoglobinopathy in Children | Bone Marrow Aplasia

France
Centre Hospitalier Universitaire de Besancon

Recruiting

Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment, and Its Influence on Quality of Life (PRISM)

Tumor With Bone Metastasis

France
European Society for Blood and Marrow Transplantation
Novartis; Pfizer

Completed

hATG+CsA vs hATG+CsA+Eltrombopag for SAA (RACE)

Severe Aplastic Anemia

Switzerland, Netherlands, France, Italy, Spain, United Kingdom
Tools4Patient

Completed

A Study to Collect Data About Analgesia in Patients With Bone Metastasis

Bone Metastasis

Belgium, France
Central Hospital, Nancy, France

Unknown

Evaluation of Sodium Fluoride PET in the Identification of Bone Metastases in Patients Having Undergone a Choline PET for Occult Recurrence of Prostatic Adenocarcinoma (FNa-CHOLINE)

Bone Metastasis

France
Centre Leon Berard

Withdrawn

A Study to Assess a Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Allografts (EVAADE)

Myelodysplastic Syndromes | Severe Combined Immunodeficiency | Acute Leukemia | Haematological Malignancy | Hemoglobinopathy in Children | Bone Marrow Aplasia

France
Assistance Publique - Hôpitaux de Paris

Completed

Microcephaly Genetic Deficiency in Neural Progenitors (MICROFANC)

Microcephaly

France
Regeneron Pharmaceuticals

Recruiting

REGN7257 in Adult Patients With Severe Aplastic Anemia That Is Refractory to or Relapsed on Immunosuppressive Therapy

Severe Aplastic Anemia (SAA)

United States, France, Korea, Republic of, United Kingdom
Centre Hospitalier Universitaire, Amiens

Unknown

Identification of Molecular Defects in Idiopathic Cytopenia of Undetermined Significance (AMICUS)

Myelodysplastic Syndromes

France
Lille Catholic University

Completed

Role of the Circulating Procoagulants Microparticles in the Hypercoagulability of MNP Ph1- (MICROP-SMP)

Myeloproliferative Neoplasm

France
AOP Orphan Pharmaceuticals AG
PharmaEssentia Corporation (Co-Sponsor for USA)

Completed

Study to Assess the Self-administration of AOP2014 Using a Pen, Developed for the Treatment of Polycythemia Vera Patients (PEN-PV)

Polycythemia Vera

Austria, Bulgaria, Czech Republic, France, Hungary, Poland, Slovakia, Ukraine
Fonds de Dotation HTC Project
Pfizer; Gilead Sciences; Novartis Pharmaceuticals; University Hospital, Clermont-Ferrand and other collaborators

Recruiting

Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support (NSFM)

Hematologic Diseases | Bone Marrow Transplantation | Hematopoietic Stem Cell Transplantation

France
French Innovative Leukemia Organisation

Completed

JAK2 Inhibitors RUXOLITINIB in Patients With Myelofibrosis

Myelofibrosis

France
European Society for Blood and Marrow Transplantation
CHUGAI sanofi-aventis

Terminated

Randomized Study In Severe Aplastic Anemia Patients Receiving Atg, Cyclosporin A, With Or Without G-CSF (SAA-G-CSF) (SAA-G-CSF)

Aplastic Anaemia

France, Netherlands, Germany, United Kingdom, Switzerland, Italy, Sweden, Greece, Czechia
Kartos Therapeutics, Inc.

Unknown

KRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia Vera

Polycythemia Vera

United States, Poland, Spain, Germany, Hungary, France
University Hospital, Angers

Not yet recruiting

Clonal Architecture of ASXL1-mutated Myelofibrosis (CLONEMF)

Myelofibrosis

France
Italfarmaco

Completed

A Two-part Study to Assess the Safety and Preliminary Efficacy of Givinostat in Patients With Polycythemia Vera

Polycythemia Vera

Germany, Poland, United Kingdom, Italy, France
University Hospital, Grenoble
Novartis

Recruiting

Evaluating Low-dose Deferasirox (DFX) in Patients With Low-risk MDS Resistant or Relapsing After ESA Agents (LODEFI)

Myelodysplasia

France
Centre Hospitalier Universitaire Dijon

Completed

Efficacy of Heat-shock Protein (HSP) Inhibitors in Myeloproliferative Syndromes (MPS) (HSP-SMP)

Myeloproliferative Syndrome

France
University Hospital, Bordeaux

Completed

Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative Neoplasms (PhiNESS)

Polycythemia Vera | Essential Thrombocythemia

France
Washington University School of Medicine
St. Louis Children's Hospital

Recruiting

Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

Hemoglobinopathies | Metabolic Disorders | Hematologic, Immune, or Bone Marrow Disorders | Non-malignant Disorders

United States, Canada
University Hospital, Bordeaux

Recruiting

Impact of Epigenetic Age on Clinic-biological Presentation and Prognosis in Myeloproliferative Neoplasms Epigenetic Age in Myeloproliferative Neoplasms (EpiC) (EpiC)

Myeloproliferative Neoplasm

France
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Microcephaly, Fanconi Anemia and Praxial Disorders (MicroFancII)

Fanconi Anemia

France
AOP Orphan Pharmaceuticals AG
PharmaEssentia Corporation (for the U.S.)

Completed

AOP2014 vs. BAT in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study. (CONTI-PV)

Polycythemia Vera

Spain, Austria, Bulgaria, France, Germany, Hungary, Poland, Romania, Russian Federation, Slovakia, Ukraine, Czechia

Clinical Trials on Bone Marrow Disease in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations